Intravitreal injection of triamcinolone acetonide for diabetic macular edema: principles and practice.
Indian J Ophthalmol
;
2006 Jun; 54(2): 133-7
Artigo
em Inglês
| IMSEAR
| ID: sea-71683
ABSTRACT
Diabetic retinopathy is fast emerging as a leading cause of newly diagnosed legal blindness amongst the working population. Macular edema, as it is commoner, accounts for more vision impairment than neovascular proliferation in diabetic patients. Laser photocoagulation, which is the standard treatment of macular edema, is associated with significant complications and an improvement in visual acuity is unsatisfactory. Intravitreal injection of corticosteroids (especially triamcinolone acetonide) is an emerging treatment modality in the management of diabetic macular edema. This article presents an overview of the principles, technique and complications associated with this procedure.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Corpo Vítreo
/
Humanos
/
Triancinolona Acetonida
/
Edema Macular
/
Resultado do Tratamento
/
Retinopatia Diabética
/
Glucocorticoides
/
Injeções
Idioma:
Inglês
Revista:
Indian J Ophthalmol
Ano de publicação:
2006
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS